# Codex Review: source_ledger_chinese_labels_20260713

Date: 2026-07-13
Delegated-agent output: `runs/hermes_source_ledger_chinese_labels_20260713.md`

## Verdict

Pass with one Codex wording refinement.

## Boundary Check

- The delegated run read the bounded context plus `/Users/smkzw/.hermes/SOUL.md` and wrote only `runs/hermes_source_ledger_chinese_labels_20260713.md`.
- No source, production-data, browser, or external-web authority was delegated.

## Codex Verification

- Compared every reviewed label with `frontend/src/App.jsx` and the final MY009/RUX desktop screenshots.
- Confirmed the UI keeps technical, content-consistency, and use status as three separate axes.
- Confirmed override changes only `use_status`; warning/mismatch remains visible and the action requires all warning checks, an explicit acknowledgement, and a substantive reason.
- Retained `安全性医学复核listing`: this role is a data-listing intake contract, while `列表` would be less specific.
- Refined `技术失败阻断` to `技术读取失败（阻断）` so the filter names both the observed condition and its workflow consequence. Backend enum and behavior remain unchanged.

## Delegated-Agent Output Review

- The output traced all 25 phrases to the supplied context and separated two mild suggestions from retained labels.
- Its conclusion that `非试验用药（CM）` and `试验用药/剂量调整` remain separate agrees with the implemented validator and UI checks.
- The statement that no residual uncertainty remained was too strong because rendered fit and state-machine behavior were outside the delegated role; Codex independently verified those surfaces.

## Residual Risk

The wording change passed 23 focused source-registry tests, the production build, and the final isolated-Chrome source-ledger regression. No clinical or regulatory content decision is delegated to the label reviewer.
